Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Paroxetine Versus Bupropion for Suicide Ideators or Attempters With Major Depressive Disorder

NCT00429169 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT00429169
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00429169 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Paroxetine Versus Bupropion for Suicide Ideators or Attempters With Major Depressive Disorder
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Terminated
Start date
June 30, 2004
Completion date
January 31, 2013
Enrollment
101 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression